The 21-aminosteroid 16-desmethyl tirilazad mesylate prevents necroinflammatory changes in experimental alcoholic liver disease

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 406-412

  Sadrzadeh, S M Hossein ^a   Nanji, Amin A ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 AMINOSTEROID; ADENOSINE TRIPHOSPHATASE (CALCIUM); ALCOHOL; CALMODULIN; CYCLOOXYGENASE 2; ENDOTOXIN; FISH OIL; GLUCOSE; LIPID PEROXIDE; MESSENGER RNA; NONHEME IRON PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL BLOOD LEVEL; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FATTY LIVER; INTRAGASTRIC DRUG ADMINISTRATION; LIPID PEROXIDATION; LIVER HISTOLOGY; LIVER NECROSIS; MALE; MEMBRANE STABILIZATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIOXIDANTS; CYCLOOXYGENASE 2; ISOENZYMES; LIPID PEROXIDATION; LIVER DISEASES, ALCOHOLIC; MALE; NECROSIS; PREGNATRIENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031886960     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Artiss JD, Vinogradov S and Zak B (1982) Spectrophotometric study of several sensitive reagents for serum iron. Clin Biochem 14:311-315.
2. Bacon BR and Britton RS (1990) The pathology of hepatic iron overload: A free radical-mediated process. Hepatology 11:127-137.
3. Baeuerle P and Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
4. Bagchi M, Ghosh S, Bagchi D, Hassoun E and Stohl SJ (1995) Protective effects of lazaroid U74389F (tirilazad mesylate) on endrin-induced lipid peroxidation and DNA damage in brain and live rand regional distribution of catalase activity in rat brain. Free Rad Biol Med 19:867-872.
5. Bonkovsky HL, Banner BF, Lambrecht RW and Rubin RB (1996) Iron in liver diseases other than hemochromatosis. Semin Liver Dis 16:65-82.
6. Braughler MJ and Pregenzer JF (1989) The 21-aminosteroid inhibitors of lipid peroxidation: Reactions with lipid peroxyl and phenoxy radicals. Free Rad Biol Med 7:125-130.
7. Braughler MJ, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ and McCall JM (1987) Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262:10438-10440.
8. Brittenham GM (1988) Development of iron-chelating agents for clinical use. Blood 80:569-569-574.
9. Cederbaum AI (1989) Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Rad Biol Med 7:537-539.
10. Chaudri G and Clark IA (1989) Reactive oxygen species facilitate the in-vitro and in-vivo lipopolysaccharide-induced release of tumor necrosis factor. J Immunol 143:1290-1297.
11. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
12. Dinchuk JE, Car BD, Focht RJ, Johnson JJ, Jaffee BD, Covington BD, Contel NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, Trzaskos JM. (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406-409.
13. 2+)-ATPase activity of human erythrocytes membranes by hemolysis in isosmotic imidazole buffer. Biochim Biophys Acta 471:49-58.
14. Feng L, Xia Y, Garcia GE, Hwang D and Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α and lipopolysaccharide. J Clin Invest 96:1669-1675.
15. French SW, Miyamoto K and Tsukamoto H (1986) Ethanol-induced fibrosis in the rat: Role of the amount of dietary fat. Alcohol Clin Exp Res 10:13S-19S.
16. French SW, Wong K, Jui L, Albano E, Hagbjork AL and Ingelman-Sundberg M (1993) Effect of ethanol on cytochrome P450 2E1 (CYP 2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 58:61-75.
17. Gossart S, Cambon C, Orfilia C, Seguelas MH, Lepert JC, Rami J, Carre P and Pipy B (1996) Reactive oxygen intermediates as regulators of TNF-α production in rat lung inflammation induced by silica. J Immunol 156:1540-1548.
18. Hall ED, McCall JM and Means ED (1994) Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 28:221-268.
19. Hall ED and Travis MA (1988) Effects of the nonglucocorticoid 21-aminosteroid U-74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage. Exp Neurol 102:244-248.
20. Hempel SL, Monick MM and Hunninghake GW (1994) Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 93:391-396.
21. Hla T, Ristimaki A, Appleby S and Barriocanal JG (1993) Cyclooxygenase gene expression in inflammation and angiogenesis. Ann N Y Acad Sci 696:197-204.
22. +K)-activated adenosine triphosphatase produced by chronic administration of ethanol. J Pharmacol Exp Ther 174:330-336.
23. Liu P, Vonderfecht SL, McGuire GM, Fisher MA, Farhood A and Jaeschke H (1994) The 21-aminosteroid tirilizad mesylate protects in a model of endotoxin shock and acute liver failure in rats. J Pharmacol Exp Ther 271:438-445.
24. McClain CJ and Cohen DA (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349-351.
25. McClain CJ, Hill D, Schmidt J and Diehl AM (1993) Cytokines and alcoholic liver disease. Sem Liver Dis 13:170-182.
26. Morimoto M, Zern MA, Hagbjork AL, Ingelman-Sundberg M and French SW (1994) Fish oil alcohol and liver pathology: Role of cytochrome P450 2E1. Proc Soc Exp Biol Med 207:197-205.
27. Morrow JD, Awad JA, Kato T, Takahashi K, Badr KF, Roberts LJ and Burk PF (1992) Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. J Clin Invest 90:2502-2507.
28. Nanji AA and French SW (1989) Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci 44:223-227.
29. Nanji AA, Khwaja S, Tahan SR and Sadrzadeh SMH (1994a) Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J Pharmacol Exp Ther 269: 1280-1285.
30. Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR and Dannenberg AJ (1997) Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 112:943-951.
31. Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F, Meydani M and Dannenberg AJ (1995) Dietary saturated fatty acids: A novel treatment for alcoholic liver disease. Gastroenterology 109:547-554.
32. Nanji AA and Zakim A (1996) Alcoholic liver disease, in Hepatology: A Textbook of Liver Disease, 3rd ed (Zakim D, Boyer TD, eds) pp 891-961, WB Saunders, Philadelphia.
33. Nanji AA, Zhao S, Sadrzadeh SMH, Dannenberg AJ, Tahan SR and Waxman DJ (1994b) Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol fed rats. Alcohol Clin Exp Res 18:1280-1285.
34. Nanji AA, Zhao S, Sadrzadeh SMH and Waxman DJ (1994c) Use of reverse-transcription polymerase chain reaction to evaluate in-vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 19:1483-1487.
35. Nordmann R, Ribiere C and Rouach H (1992) Implication of free radical mechanisms in ethanol-induced cellular injury. Free Rad Biol Med 12:219-240.
36. Ohkawa H, Ohishi N and Yagi K (1979) Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
37. Pham TV, Nanji AA, Kong TL, Lin M, Yin W, Wang SC, Ohata M and Tsukamoto H (1996) Iron and unsaturated fat as nutritional pro-oxidants: NF-κB activation and induction of TNF-α and MIP-1 in experimental alcoholic liver disease (Abstract). Hepatotogy 24:185A.
38. Reinke LA, Lai EK, Dubose CM and McCay PB (1987) Reactive free radical generation in vivo on heart and liver of ethanol-fed rats: Correlation with radical formation in vitro. Proc Natl Acad Sci USA 84:9223-9227.
39. Sadrzadeh SMH, Nanji AA and Price PL (1994b) The oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats. J Pharmacol Exp Ther. 269:632-636.
40. Sadrzadeh SMH, Price P and Nanji AA (1994a) Ethanol-induced changes in membrane ATPases: Inhibition by iron chelation. Biochem Pharmacol 47:745-747.
41. Sadrzadeh SMH, Vincenzi FF and Hinds RR (1993) Simultaneous measurement of membrane ATPases in microtiter plates. J Pharmacol Toxicol Methods 30:103-110.
42. Schreck R and Baeuerle P (1991) A role for oxygen radicals as second messengers. Trends Cell Biol 1:39-42.
43. Shaw S and Jayatilleke E (1992) The role of cellular oxidases and catalytic iron in the pathogenesis of ethanol-induced liver injury. Life Sci 50:2045-2052.
44. Shaw S, Jayatilleke E and Lieber CS (1988) Lipid peroxidation as a mechanism of alcoholic liver injury: Role of iron mobilization and microsomal induction. Alcohol 5:135-140.
45. Suzuki YJ, Forman HJ and Sevanian A (1997) Oxidants as stimulators of signal transduction. Free Rad Biol Med 22:269-285.
46. Taylor BM, Fleming WE, Benjamin CW, Wu Y, Mathews WR and Sun FF (1996) The mechanism of cytoprotective action of lazaroids: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J Pharmacol Exp Ther 276:1224-1231.
47. Tsukamoto H, Gaal K and French SW (1990) Insight into the pathogenesis of alcoholic liver necrosis and fibrosis. Hepatology 12:599-608.
48. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkaila S, Yla-Hertiuala F and Brittenham GM (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-630.
49. Wang Y, Mathews WR, Guido DM and Jaeschke H (1996) The 21-aminosteroid tirilizad mesylate protects against injury via membrane stabilization not inhibition of lipid peroxidation. J Pharmacol Exp Ther 277:714-720.
50. Wei N and Sadrzadeh SMH (1994) Enhancement of hemin-induced membrane damage by artemisinin. Biochem Pharmacol 48:737-741.